SEC Form 4 · accession 0001562180-16-001338
Ultragenyx Pharmaceutical Inc. · RARE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Theodore Alan Huizenga
Officer — Controller and PAO
Period of report
Jan 14, 2016
Accepted (ET)
Jan 19, 2016 · 4:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001515673
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 14, 2016 | M | 1,000 | $21.00 | A | 3,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF2,F1 | $21.00 | Jan 14, 2016 | M | 1,000 | D | — | Jan 29, 2024 | Common Stock | 1,000 | 25,403 | D |
Explanation of responses
- F11/4 of the shares underlying the option vested on January 27, 2015 and then 1/48th of the underlying shares will vest monthly thereafter, provided the Reporting Person has not terminated services with the Issuer.
- F2Due to clerical error, the Forms 4 filed by the Reporting Person on each of June 19, 2015 and December 18, 2015 listed incorrect amounts in Column 9. The Form 4 filed on June 19, 2015 should have listed 27,903 instead of 0 and the Form 4 filed on December 18, 2015 should have listed 26,403 instead of 13,955.